Barbara Vanderhyden, Canada
Characterizing the tumour microenvironment of syngeneic mouse models of ovarian cancer to predict response to immunotherapy

Céline M. Laumont, Canada
Deciphering T & B-cell responses to ovarian cancer

Kristianne JC Galpin, Canada
Investigating FGL2 as a therapeutic target in ovarian cancer

Deyang Li, Canada
Interferon associated adaptive immune resistance represented by immune checkpoint expression and immune cell localization in high-grade serous ovarian cancer

Douglas Chung, Canada
Tumour-infiltrating T cells in patients with clear cell ovarian carcinoma display reduced expression of immune checkpoint molecules in comparison to high-grade serous ovarian carcinoma

Jessica Gosse, Canada
Molecular imaging analysis of combination immunotherapy in an epithelial ovarian cancer preclinical animal model